Skip to main content

ASO Author Reflections: Esophageal Squamous Cell Carcinoma—Still a Conundrum

This is a preview of subscription content, access via your institution.


  1. 1.

    Shapiro J, van Lanschot JJB, Hulshof M, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090–8.

    Article  Google Scholar 

  2. 2.

    Squires MH, Gower N, Benhow JH, et al. PET imaging and rate of pathologic complete response in esophageal squamous cell carcinoma. Ann Surg Oncol. 2021.

  3. 3.

    Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749–62.

    Article  Google Scholar 

  4. 4.

    Simonsen C, de Heer P, Bjerre ED, et al. Sarcopenia and postoperative complication risk in gastrointestinal surgical oncology: a meta-analysis. Ann Surg. 2018;268(1):58–69.

    Article  Google Scholar 

  5. 5.

    Eyck BM, van der Wilk BJ, Noordman BJ, et al. Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer. Trials. 2021;22(1):345.

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Jonathan C. Salo MD, FACS.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Squires, M.H., Salo, J.C. ASO Author Reflections: Esophageal Squamous Cell Carcinoma—Still a Conundrum. Ann Surg Oncol (2021).

Download citation